We are delighted to announce that Chimera Bioengineering is the latest company to join the Kairos portfolio. Founded in...

Read more

We are pleased to announce that Transient Plasma Systems (TPS) is the latest company to join the Kairos portfolio....

Read more

Healthline recently published an article on the importance of implantable drugs, including Delpor’s implant devices. The first half of...

Read more

This month, Axial Biotherapeutics announced the appointment of leading experts in the Autism Spectrum Disorders (ASD) field to its...

Read more

We are proud to announce that Kairos Venture Partners II, L.P., our second fund, has made its second investment...

Read more

We are excited to announce that Kairos Venture Partners II, L.P., our second fund, has made its first investment...

Read more
By: Kairos Ventures On: 25 Jun In: Kairos News

We would like to welcome six new team members to Kairos Ventures: Danielle Walker, Chris Del Vecchio and Shahed...

Read more

Kairos portfolio company, Compellon, appointed software and services veteran Carv Moore as its Chief Executive Officer to lead the...

Read more
By: Kairos Ventures On: 15 Jun In: Delpor

The NIDDK continues to fund Delpor's efforts to utilize its NANOPORâ„¢ technology in developing a matchstick-size subcutaneous implant device...

Read more
By: Kairos Ventures On: 11 Jun In: Kairos News

We are happy to announce that Travis Blake has joined the Kairos team as the Principal for Physical Sciences,...

Read more